Windward Bio

Company develops monoclonal antibody therapeutics for immunological and respiratory diseases

placeBasel, Basel Stadt, Switzerland calendar_todayFounded 2020 language windwardbio.com

Social engagement

Social engagement: 3.9K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

16 investors on record; lead investors include Novo Holdings, Orbimed, Blue Owl.

Investor typeCountShare
Venture capital1169%
Private equity16%
Other / undisclosed425%

Recent activity

9 Jun 2026
Milestone
regulatory
22 Dec 2025
Partnership
Windward Bio
Coming soon